The BioInMed Polish Association of Innovative Medical Biotechnology Companies was established by 11 companies, i.e. Ardigen SA, Captor Therapeutics SA, Celon Pharma SA, ExploRNA Therapeutics SA, OncoArendi Therapeutics SA, Polski Bank Komórek Macierzystych SA, PolTREG SA, Pure Biologics SA, Ryvu Therapeutics SA, Selvita SA and WPD Pharmaceuticals Sp. z o.o.

The Association was created in order to, in collaboration with all stakeholders and public administration, build the infrastructure that enables medical biotechnology to become the showcase of Polish innovation and may also be a driving force for the economy in the future.